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27 outpatients with severe 
low dose enatapril were well tolerated in 
Fewer clinical events occurred in patients 
ate also suggest that high plasma NE levels 
predict clinical events. 
lous, James Conway, 
eter Sleight. Oxford University, Oxford, Unit 
To establish whether physical training(Tr) has ~mpara~le/additive 
effects to Lisinopril (Lis) 10 mg/day, we entered 12 male Pts(aged: 
67H yrs) with moderate to severe heart faiiure(EF=t6*5%), all 
of whom were considered by independant clinicians to require con- 
verting enzyme inhibitors, into a placebo-controlled, cross-over 
trial. After a 4 week run-in phase during which 3 baseline exercise 
tests were obtained, Pts were randomly aiioca to 4 crossover 
periods of 6 weeks each. These included: pia 
detraining (DTr), Lis and Tr, and Lis and DT 
on a bicycle ergometer for 20 min/day for 5 days/week at 60-60% 
of their maximal workload. Compliance to Tr was 85H5%. Results 
are shown in the tabie(HR submax=Heart Rate at submaximal work- 
load; Max 02=maximal 02 consumption; SBP,DBP = systolic and 
to severe heart failure was enhanced by Tr whether or not they were 
on Lis. 2. While there was no clear benefit from Lis alone, a non 
significant trend was shown for the combination of Lis and Tr to be 
better than Tr alone. 3. Tr may be a useful adjunct to the existing 
medical therapy for heart failure. 
Does Arterial Patency 90 fnutes ?‘ollowing Thrombolyt%c 
Therapy Predict 42 Day Survival? 
Florence H. Sheehan, 9. Ward Kenne- 
tissue plasmin- 
ocardial Infarc- 
tion Trial (TIM) phase I ware to determine if 
90 min patency of the infarct related vessel predicts 42 
day survival. Patency (TINI grade O-3) was evaluated 
by the core laboratory The centerline method 
to calculate the circumferential extent of 
is more severe than 2SD below normal (hypo- 
length). Mortality for no perfusion (TIM grade 3) 
was compared with abnormal usion (TIM grade O-2) 
txesults : Wnivariate an sis showed lower mortality 
I grade 3 (normal) flow: 
Grade e! B ?I2 
0 90 
1 33 
2 115 <0.005 
3 150 4.7 4.7 
Mortality was less well predicted by separating pts into 
flow grade 0 or 1 (10.6%) vs grade 2 or 3 (5.7%). 
p-0.08. Cn multivariate analysis of clinical and angio- 
graphic parameters, the strongest predictor of survival 
was LV function. Cox regression summary: * 
Chi Square 
Hype-length 9.1 oPoo3 
Age 6.9 0.01 
Conclusion: Although LV function remains as the single 
most prognostic indicator, achievement of normal perfu- 
sion (TIM grade 3) following thrombolytic therapy may 
be important for improved survival. 
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Bernard&o Tranchesi Jr., Cicero Albuquerque, Bruno Caramelli, 
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nCor, sa”o Pauio, Brazil. 
is study was designed to analyze the presence of benefit 
m temporary reperfosion after r-t - PA infusion. 120 patients 
with AIMI ( < 5 hours) were submitted to coronary angiograms 
to document total occlusion of the infarct related artery (IRA) 
followed by r-t - PA infusion. IRA patency was assessed every 
15’ for 90’ and the angiograms were repeated 24 hours later. 
The patients were divided in 3 groups after the coronariographies: 
A. reperfusion of the IRA (e.g. patency in at least one of the 
angiograms but not in the last one); 5. maintained reperfusion; 
C. maintained occlusion of the IRA. Mortality was 7.1% (2 / 281, 
7.0% (4 / 57) aid 22.9% (8 / 35) for A, B, and C (P = 0.05). 
In our sample, 53me patients with temporary reperfusion 
represented a special set of patients with a better short term 
prognosis. We may hypothesize that despite hawrng an occluded 
IRA they have benefited from temporary reperfusion. 
GROUP N Age 
A 28 53.6 
57 54.7 
c 35 54.2 
Delay 
234 
233 
230 
IRA 
12 LAD 
15 RCA 
1 CFX 
29 LAD 
26 RCA 
2 CFX 
12 LAD 
18 RCA 
5 CFX 
Death 
2 ( 7.1%) 
4 6 7.696) 
8 (22.9%) 
P NS NS NS p = 0.05 
